Skip to main content
. 2017 Nov 13;34(1):52–59. doi: 10.1007/s12291-017-0715-9

Table 2.

Cardiovascular risk assessment in rheumatoid arthritis and systemic lupus erythematosus patients

Groups based on atherogenic index of plasma Rheumatoid arthritis Systemic lupus erythematosus P value
Low risk (< 0.11) 8 0 0.007
Intermediate risk (0.11–0.24) 2 1
High risk (> 0.24) 5 8